Skip to content

Study of the effects of grapefruit extract on COVID-19

Pilot study of the Grapefruit seed extract adjuvant therapy on COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140312016968N2
Enrollment
20
Registered
2020-11-01
Start date
2020-04-21
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: For 7 days, three times a day, each time 10 drops of grapefruit seed extract in addition to routine medication that is Kaltra receive. The medicine should be poured

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Ages between 18-60 years Inpatients of the wards Daily Lopinavir / Ritonavir PCR confirmed COVID-19 Without background disease

Exclusion criteria

Exclusion criteria: Age above 60 and below 18 Cardiovascular disease Diabetes Autoimmune disease Renal disease Respiratory distress on admission time Allergy history Consumption of cardiovascular drugs, anti diabetes, anti coagulants, anti HIV, anti cholesterol, immunsuppressive, and cancer chemotherapy agents Reluctance to participate in the study

Design outcomes

Primary

MeasureTime frame
O2 saturation. Timepoint: Measurement of oxygen saturation every day during the study. Method of measurement: Pulse oximetry device.;Adverse drug reaction. Timepoint: Daily recording of possible adverse effects of the extract. Method of measurement: Observational recording.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Marjani

Shahid Beheshti University of Medical Sciences

marjani216@hotmail.com+98 21 2610 5050

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026